MA25912A1 - Sels de sodium de 5- (4-(2-(n-methyl-n-(2-pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione - Google Patents

Sels de sodium de 5- (4-(2-(n-methyl-n-(2-pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione

Info

Publication number
MA25912A1
MA25912A1 MA27076A MA27076A MA25912A1 MA 25912 A1 MA25912 A1 MA 25912A1 MA 27076 A MA27076 A MA 27076A MA 27076 A MA27076 A MA 27076A MA 25912 A1 MA25912 A1 MA 25912A1
Authority
MA
Morocco
Prior art keywords
thiazolidine
dione
pyridyl
ethoxy
benzyl
Prior art date
Application number
MA27076A
Other languages
English (en)
Inventor
Andrew Simon Craig
Michael Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MA25912A1 publication Critical patent/MA25912A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA27076A 2000-09-29 2003-03-28 Sels de sodium de 5- (4-(2-(n-methyl-n-(2-pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione MA25912A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0023971.5A GB0023971D0 (en) 2000-09-29 2000-09-29 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
MA25912A1 true MA25912A1 (fr) 2003-10-01

Family

ID=9900428

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27076A MA25912A1 (fr) 2000-09-29 2003-03-28 Sels de sodium de 5- (4-(2-(n-methyl-n-(2-pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione

Country Status (27)

Country Link
US (4) US20040014752A1 (fr)
EP (2) EP1813612A1 (fr)
JP (1) JP2004509959A (fr)
KR (1) KR100917953B1 (fr)
CN (4) CN101125853A (fr)
AP (1) AP1738A (fr)
AU (2) AU2001292028B2 (fr)
BG (1) BG107679A (fr)
BR (1) BR0114308A (fr)
CA (1) CA2423975A1 (fr)
CZ (1) CZ302181B6 (fr)
DZ (1) DZ3480A1 (fr)
EA (1) EA005109B1 (fr)
EC (1) ECSP034528A (fr)
GB (1) GB0023971D0 (fr)
HU (1) HUP0301188A3 (fr)
IL (2) IL155051A0 (fr)
MA (1) MA25912A1 (fr)
MX (1) MXPA03002868A (fr)
NO (2) NO20031435L (fr)
NZ (1) NZ524933A (fr)
OA (1) OA12399A (fr)
PL (1) PL363701A1 (fr)
SK (1) SK3782003A3 (fr)
UA (1) UA74842C2 (fr)
WO (1) WO2002026735A1 (fr)
ZA (1) ZA200302439B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8133637B2 (en) * 2005-10-06 2012-03-13 Headwaters Technology Innovation, Llc Fuel cells and fuel cell catalysts incorporating a nanoring support
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
CA2783556C (fr) * 2009-12-15 2017-12-12 Metabolic Solutions Development Company, Llc Thiazolidinediones epargnant les ppar et associations pour le traitement de maladies neurodegeneratives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG59988A1 (en) * 1987-09-04 1999-02-22 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9124513D0 (en) * 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9308487D0 (en) * 1993-04-23 1993-06-09 Smithkline Beecham Plc Novel compounds
GB9723295D0 (en) * 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
CN1253236A (zh) * 1998-11-11 2000-05-17 李扬远 一种以重力差释放引力能的方法
CN1183130C (zh) * 1999-09-24 2005-01-05 中国人民解放军军事医学科学院毒物药物研究所 噻唑烷类衍生物及其医药用途
HU225919B1 (en) * 1999-12-18 2007-12-28 Richter Gedeon Nyrt Thiazolidine-derivatives, process for their preparation pharmaceutical and intermediates
GB0006133D0 (en) * 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
EP1813612A1 (fr) 2007-08-01
PL363701A1 (en) 2004-11-29
MXPA03002868A (es) 2004-12-06
EA200300422A1 (ru) 2003-08-28
GB0023971D0 (en) 2000-11-15
NZ524933A (en) 2004-12-24
HUP0301188A2 (hu) 2003-11-28
HUP0301188A3 (en) 2005-04-28
CN101125853A (zh) 2008-02-20
ZA200302439B (en) 2004-04-28
DZ3480A1 (fr) 2002-04-04
AP2003002767A0 (en) 2003-03-31
NO20076517L (no) 2003-04-29
BG107679A (bg) 2003-12-31
SK3782003A3 (en) 2004-06-08
UA74842C2 (en) 2006-02-15
KR20030039377A (ko) 2003-05-17
NO20031435D0 (no) 2003-03-28
CN1466585A (zh) 2004-01-07
BR0114308A (pt) 2003-10-14
CZ2003850A3 (cs) 2004-03-17
CA2423975A1 (fr) 2002-04-04
WO2002026735A1 (fr) 2002-04-04
CN1915992B (zh) 2010-05-12
KR100917953B1 (ko) 2009-09-21
OA12399A (en) 2004-09-06
US20060004058A1 (en) 2006-01-05
AP1738A (en) 2007-05-07
CN1915992A (zh) 2007-02-21
US20040214866A1 (en) 2004-10-28
EP1332142A1 (fr) 2003-08-06
US20050277679A9 (en) 2005-12-15
ECSP034528A (es) 2003-05-26
US20040014752A1 (en) 2004-01-22
EA005109B1 (ru) 2004-10-28
JP2004509959A (ja) 2004-04-02
IL188116A0 (en) 2008-03-20
CN101125852A (zh) 2008-02-20
NO20031435L (no) 2003-05-27
AU2001292028B2 (en) 2005-04-21
CN100345846C (zh) 2007-10-31
US20070185167A1 (en) 2007-08-09
IL155051A0 (en) 2003-10-31
AU9202801A (en) 2002-04-08
CZ302181B6 (cs) 2010-12-01

Similar Documents

Publication Publication Date Title
NO20024307L (no) Hydrokloridsalter av 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoksy]benzyl]tiazolidin-2,4-dion
NO20015147D0 (no) Polymorf av 5-(4-(2-(N-metyl-N-(2- pyridyl)amino)etoksy)benzyl)tiazolidin-2,4-dion, maleinsyresalt
AU9123201A (en) Novel polymorphic forms of 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl) thiazolidine-2,4-dione maleate and process for their preparation
IL136424A0 (en) 5-[4-[2-(n-methyl-n-(2-pyridyl)amino) ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
DZ3475A1 (fr) Le sels hydrochloridrates de 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
IL188116A0 (en) Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione
DK1349855T3 (da) 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin-2,4-dionmesylatsalt
SI1265893T1 (sl) Hidrokloridne soli 5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil)tiazolidin-2,4-diona
AU6255001A (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical
SI1173435T1 (en) Polymorph of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione maleic acid salt
AU2002222305A1 (en) 5-'4-'2-(n-methyl-n- (2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione mesylate salt